Duration of isolation and contagiousness in coronavirus disease 2019 (COVID-19) patients receiving tocilizumab and dexamethasone: A case series.
Florence CôtéGuy BoivinVilayvong LoungnarathAnnie RuestJulie Bestman-SmithJulie CarbonneauMarie-Ève HamelinMarie-Claude RoyPublished in: Infection control and hospital epidemiology (2022)
We describe 10 patients with severe coronavirus disease 2019 (COVID-19) who received tocilizumab and dexamethasone. We correlated isolation duration with cycle thresholds (Ct) values of nucleic acid amplification tests, clinical state and viral cultures. Isolation duration exceeded 21 days for 7 patients due to positive viral cultures or Ct values <30.
Keyphrases
- coronavirus disease
- nucleic acid
- sars cov
- rheumatoid arthritis
- respiratory syndrome coronavirus
- end stage renal disease
- computed tomography
- image quality
- ejection fraction
- low dose
- chronic kidney disease
- contrast enhanced
- juvenile idiopathic arthritis
- newly diagnosed
- dual energy
- rheumatoid arthritis patients
- peritoneal dialysis
- prognostic factors
- early onset
- magnetic resonance imaging
- magnetic resonance
- positron emission tomography
- systemic lupus erythematosus